US Stock MarketDetailed Quotes

MBRX Moleculin Biotech

Watchlist

2.6700
-0.0600-2.20%

Trading Nov 25 13:04 ET

8.02MMarket Cap-223P/E (TTM)

Moleculin Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

19.98%7.14M

-3.53%6.19M

-20.07%6.68M

-3.29%29.63M

26.55%8.92M

-34.53%5.95M

-13.76%6.41M

18.09%8.35M

33.40%30.64M

35.41%7.05M

Selling and administrative expenses

-17.57%2.17M

-17.17%2.06M

-9.25%2.39M

-13.21%10.02M

-20.65%2.25M

-14.64%2.64M

-22.03%2.49M

8.88%2.64M

37.63%11.54M

42.47%2.84M

-General and administrative expense

-17.57%2.17M

-17.17%2.06M

-9.25%2.39M

-13.21%10.02M

-20.65%2.25M

-14.64%2.64M

-22.03%2.49M

8.88%2.64M

37.63%11.54M

42.47%2.84M

Research and development costs

50.37%4.93M

5.20%4.09M

-25.23%4.25M

2.74%19.49M

58.74%6.63M

-45.01%3.28M

-7.52%3.89M

23.10%5.69M

31.56%18.97M

31.42%4.18M

Depreciation amortization depletion

-3.13%31K

0.00%31K

6.67%32K

-2.31%127K

9.38%35K

0.00%32K

-8.82%31K

-6.25%30K

-20.73%130K

-5.88%32K

-Depreciation and amortization

-3.13%31K

0.00%31K

6.67%32K

-2.31%127K

9.38%35K

0.00%32K

-8.82%31K

-6.25%30K

-20.73%130K

-5.88%32K

Operating profit

-19.98%-7.14M

3.53%-6.19M

20.07%-6.68M

3.29%-29.63M

-26.55%-8.92M

34.53%-5.95M

13.76%-6.41M

-18.09%-8.35M

-33.40%-30.64M

-35.41%-7.05M

Net non-operating interest income expense

-68.52%102K

-59.23%159K

-38.52%241K

470.00%1.37M

107.94%262K

881.82%324K

900.00%390K

833.33%392K

-21.57%240K

80.00%126K

Non-operating interest income

-68.52%102K

-59.23%159K

-38.52%241K

470.00%1.37M

107.94%262K

881.82%324K

900.00%390K

833.33%392K

-21.57%240K

--126K

Other net income (expense)

-25,521.43%-3.56M

3,693.33%1.71M

3,019.15%1.47M

-209.53%-1.51M

-1,160.53%-1.61M

-96.82%14K

-92.72%45K

-71.52%47K

-79.68%1.38M

-93.42%152K

Gain on sale of security

-172,900.00%-1.73M

4,611.11%1.7M

3,630.77%1.46M

-178.20%-1.04M

-841.72%-1.12M

-99.76%1K

-94.03%36K

-75.63%39K

-80.16%1.34M

-93.43%151K

Other non- operating income (expenses)

-14,184.62%-1.83M

22.22%11K

37.50%11K

-1,255.00%-462K

-49,300.00%-492K

-31.58%13K

-40.00%9K

60.00%8K

0.00%40K

-90.00%1K

Income before tax

-88.84%-10.59M

27.73%-4.32M

37.21%-4.97M

-2.56%-29.77M

-51.68%-10.27M

34.86%-5.61M

11.82%-5.98M

-15.26%-7.92M

-82.62%-29.03M

-139.65%-6.77M

Income tax

Net income

-88.84%-10.59M

27.73%-4.32M

37.21%-4.97M

-2.56%-29.77M

-51.68%-10.27M

34.86%-5.61M

11.82%-5.98M

-15.26%-7.92M

-82.62%-29.03M

-139.65%-6.77M

Net income continuous Operations

-88.84%-10.59M

27.73%-4.32M

37.21%-4.97M

-2.56%-29.77M

-51.68%-10.27M

34.86%-5.61M

11.82%-5.98M

-15.26%-7.92M

-82.62%-29.03M

-139.65%-6.77M

Minority interest income

Net income attributable to the parent company

-88.84%-10.59M

27.73%-4.32M

37.21%-4.97M

-2.56%-29.77M

-51.68%-10.27M

34.86%-5.61M

11.82%-5.98M

-15.26%-7.92M

-82.62%-29.03M

-139.65%-6.77M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-88.84%-10.59M

27.73%-4.32M

37.21%-4.97M

-2.56%-29.77M

-51.68%-10.27M

34.86%-5.61M

11.82%-5.98M

-15.26%-7.92M

-82.62%-29.03M

-139.65%-6.77M

Basic earnings per share

-1.06%-2.85

43.71%-1.7

51.09%-2.02

0.99%-15.1454

-44.75%-5.2054

37.33%-2.82

16.11%-3.02

-14.72%-4.13

-72.84%-15.2961

-166.38%-3.5961

Diluted earnings per share

-1.06%-2.85

43.71%-1.7

51.09%-2.02

0.99%-15.1454

-44.75%-5.2054

37.33%-2.82

16.11%-3.02

-14.72%-4.13

-72.84%-15.2961

-166.38%-3.5961

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	19.98%7.14M	-3.53%6.19M	-20.07%6.68M	-3.29%29.63M	26.55%8.92M	-34.53%5.95M	-13.76%6.41M	18.09%8.35M	33.40%30.64M	35.41%7.05M
Selling and administrative expenses	-17.57%2.17M	-17.17%2.06M	-9.25%2.39M	-13.21%10.02M	-20.65%2.25M	-14.64%2.64M	-22.03%2.49M	8.88%2.64M	37.63%11.54M	42.47%2.84M
-General and administrative expense	-17.57%2.17M	-17.17%2.06M	-9.25%2.39M	-13.21%10.02M	-20.65%2.25M	-14.64%2.64M	-22.03%2.49M	8.88%2.64M	37.63%11.54M	42.47%2.84M
Research and development costs	50.37%4.93M	5.20%4.09M	-25.23%4.25M	2.74%19.49M	58.74%6.63M	-45.01%3.28M	-7.52%3.89M	23.10%5.69M	31.56%18.97M	31.42%4.18M
Depreciation amortization depletion	-3.13%31K	0.00%31K	6.67%32K	-2.31%127K	9.38%35K	0.00%32K	-8.82%31K	-6.25%30K	-20.73%130K	-5.88%32K
-Depreciation and amortization	-3.13%31K	0.00%31K	6.67%32K	-2.31%127K	9.38%35K	0.00%32K	-8.82%31K	-6.25%30K	-20.73%130K	-5.88%32K
Operating profit	-19.98%-7.14M	3.53%-6.19M	20.07%-6.68M	3.29%-29.63M	-26.55%-8.92M	34.53%-5.95M	13.76%-6.41M	-18.09%-8.35M	-33.40%-30.64M	-35.41%-7.05M
Net non-operating interest income expense	-68.52%102K	-59.23%159K	-38.52%241K	470.00%1.37M	107.94%262K	881.82%324K	900.00%390K	833.33%392K	-21.57%240K	80.00%126K
Non-operating interest income	-68.52%102K	-59.23%159K	-38.52%241K	470.00%1.37M	107.94%262K	881.82%324K	900.00%390K	833.33%392K	-21.57%240K	--126K
Other net income (expense)	-25,521.43%-3.56M	3,693.33%1.71M	3,019.15%1.47M	-209.53%-1.51M	-1,160.53%-1.61M	-96.82%14K	-92.72%45K	-71.52%47K	-79.68%1.38M	-93.42%152K
Gain on sale of security	-172,900.00%-1.73M	4,611.11%1.7M	3,630.77%1.46M	-178.20%-1.04M	-841.72%-1.12M	-99.76%1K	-94.03%36K	-75.63%39K	-80.16%1.34M	-93.43%151K
Other non- operating income (expenses)	-14,184.62%-1.83M	22.22%11K	37.50%11K	-1,255.00%-462K	-49,300.00%-492K	-31.58%13K	-40.00%9K	60.00%8K	0.00%40K	-90.00%1K
Income before tax	-88.84%-10.59M	27.73%-4.32M	37.21%-4.97M	-2.56%-29.77M	-51.68%-10.27M	34.86%-5.61M	11.82%-5.98M	-15.26%-7.92M	-82.62%-29.03M	-139.65%-6.77M
Income tax
Net income	-88.84%-10.59M	27.73%-4.32M	37.21%-4.97M	-2.56%-29.77M	-51.68%-10.27M	34.86%-5.61M	11.82%-5.98M	-15.26%-7.92M	-82.62%-29.03M	-139.65%-6.77M
Net income continuous Operations	-88.84%-10.59M	27.73%-4.32M	37.21%-4.97M	-2.56%-29.77M	-51.68%-10.27M	34.86%-5.61M	11.82%-5.98M	-15.26%-7.92M	-82.62%-29.03M	-139.65%-6.77M
Minority interest income
Net income attributable to the parent company	-88.84%-10.59M	27.73%-4.32M	37.21%-4.97M	-2.56%-29.77M	-51.68%-10.27M	34.86%-5.61M	11.82%-5.98M	-15.26%-7.92M	-82.62%-29.03M	-139.65%-6.77M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-88.84%-10.59M	27.73%-4.32M	37.21%-4.97M	-2.56%-29.77M	-51.68%-10.27M	34.86%-5.61M	11.82%-5.98M	-15.26%-7.92M	-82.62%-29.03M	-139.65%-6.77M
Basic earnings per share	-1.06%-2.85	43.71%-1.7	51.09%-2.02	0.99%-15.1454	-44.75%-5.2054	37.33%-2.82	16.11%-3.02	-14.72%-4.13	-72.84%-15.2961	-166.38%-3.5961
Diluted earnings per share	-1.06%-2.85	43.71%-1.7	51.09%-2.02	0.99%-15.1454	-44.75%-5.2054	37.33%-2.82	16.11%-3.02	-14.72%-4.13	-72.84%-15.2961	-166.38%-3.5961
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data